Blockade of learning and memory genes in Alzheimer’s disease – 4
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Alzheimer's disease is the most common cause of dementia in older adults, and affects as many as 5.1 million Americans. Dr. Roderick Corriveau at the NIH says new study findings could set the tone for a new treatment.
Corriveau: Well right now there's no drug or therapy that can cure, stop, or prevent Alzheimer's disease. The study is an important step in developing a new therapy or strategy for a new therapy. And this is a new therapy that would go directly to the genes that are important for making new memories.
Narrator: He adds the goal is to prevent the disease from occurring at all. For study details, visit www.ninds.nih.gov. Health Matters is produced by the NIH, part of the U.S. Department of Health and Human Services.
About NIH Audio
NIH Audio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Audio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Audio is a service of the Office of Communications & Public Liaison.